BioNexus Gene Lab (BGLC) Net Income (2018 - 2025)
BioNexus Gene Lab's Net Income history spans 8 years, with the latest figure at -$1.0 million for Q4 2025.
- Quarterly results put Net Income at -$1.0 million for Q4 2025, down 203.55% from a year ago — trailing twelve months through Dec 2025 was -$3.0 million (down 92.4% YoY), and the annual figure for FY2025 was -$3.0 million, down 87.55%.
- Net Income for Q4 2025 was -$1.0 million at BioNexus Gene Lab, down from -$708991.0 in the prior quarter.
- In the past five years, Net Income ranged from a high of $351515.0 in Q4 2023 to a low of -$2.6 million in Q3 2023.
- The 5-year median for Net Income is -$108031.5 (2022), against an average of -$334778.8.
- Peak annual rise in Net Income hit 329.64% in 2023, while the deepest fall reached 3271.0% in 2023.
- Year by year, Net Income stood at $115979.0 in 2021, then plummeted by 231.98% to -$153071.0 in 2022, then skyrocketed by 329.64% to $351515.0 in 2023, then crashed by 197.1% to -$341331.0 in 2024, then plummeted by 203.55% to -$1.0 million in 2025.
- According to Business Quant data, Net Income over the past three periods came in at -$1.0 million, -$708991.0, and -$616172.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.